Text Size

Identification of Inpatients at Risk for Poor Glycemic Control

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01043042
First received: January 4, 2010
Last updated: January 5, 2010
Last verified: January 2010
History of Changes
  Purpose

Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present at admission that identify patients at greater risk of poor inpatient glycemic control


Condition Intervention
Hypoglycemia
Hyperglycemia
 Other: No interventions will be used in this study

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Identification of Inpatients at Risk for Poor Glycemic Control

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Vanderbilt University:

Estimated Enrollment: 10000
Study Start Date: January 2010
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Hospitalized patients
patients hospitalized at VUH between 4/1/2008 to 10/31/2009
 Other: No interventions will be used in this study
No interventions will be used in this study

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Candidates for inclusion will include all adult (age ≥ 18 years) patients admitted to Vanderbilt University Medical Center from 04/01/2008 to 10/31/2009. Patients will be excluded if they were pregnant at the time of admission or had length of stay < 24 hours.

Criteria

Inclusion Criteria:

  • age ≥ 18 years
  • hospitalized in VUH

Exclusion Criteria:

  • -length of stay < 24 hours
  • pregnant women
  • patients receiving palliative/hospice care
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01043042

Locations
United States, Tennessee
Vanderbilt University Hospital
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Jeffrey Boord, MD MPH Vanderbilt University
  More Information

No publications provided

Responsible Party: Jeffrey Boord, MD, Vanderbilt University
ClinicalTrials.gov Identifier: NCT01043042     History of Changes
Other Study ID Numbers: 091507
Study First Received: January 4, 2010
Last Updated: January 5, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Vanderbilt University:
hypoglycemia among inpatients
hyperglycemia among inpatients

Additional relevant MeSH terms:
Hyperglycemia
Hypoglycemia
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on May 23, 2013